Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lumexa Imaging Holdings, Inc. ( (LMRI) ) just unveiled an update.
Lumexa Imaging reported preliminary unaudited results on March 2, 2026, for the fourth quarter and full year ended December 31, 2025, highlighting an IPO, leverage reduction, and network expansion with nine new de novo centers and one acquisition. The company expects 2025 consolidated revenue of at least $1.016 billion versus $948.9 million in 2024, an improved net loss capped at $43.8 million compared with $94.1 million, and Adjusted EBITDA of at least $229 million, supported by higher outpatient procedure volumes and a growing mix of advanced imaging.
For the fourth quarter of 2025, Lumexa Imaging anticipates consolidated revenue of at least $261 million, at least 10% system-wide revenue growth, and Adjusted EBITDA of at least $63 million, driven by strong demand for advanced outpatient imaging and improved performance at new centers. Looking ahead to 2026, the company is guiding to consolidated revenue of $1.045 billion to $1.097 billion and Adjusted EBITDA of $234 million to $242 million, with growth tempered by about $7 million in incremental public-company costs following its IPO and positioning it as a scaling, newly public player in outpatient imaging.
The most recent analyst rating on (LMRI) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Lumexa Imaging Holdings, Inc. stock, see the LMRI Stock Forecast page.
More about Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. is one of the largest U.S. providers of outpatient imaging services, operating wholly owned centers and joint ventures that offer advanced procedures such as MRI and CT. The company focuses on system-wide growth in procedure volumes and revenues across its national outpatient network, targeting higher-margin advanced imaging in ambulatory settings.
Average Trading Volume: 723,158
Current Market Cap: $1.34B
See more data about LMRI stock on TipRanks’ Stock Analysis page.